Results 111 to 120 of about 290 (122)

Cyclopropyl Glycine and Proline-Containing Preparation Noopept Evoke Two Types of Membrane Potential Responses in Synaptoneurosomes

Bulletin of Experimental Biology and Medicine, 2003
Proline, cyclo(Pro-Gly), and acyl-prolyl-containing dipeptide GVS-111 decreased synaptoneurosome membrane potential in a Ca2+-free medium. The efficiency of these preparations decreased in the following order: GVS>cyclo(Pro-Gly)>proline. Depolarization responses induced by endogenous nootropic agent cyclo(Pro-Gly) was dose-dependent and saturable; the ...
V K, Lutsenko, M N, Vukolova, T A, Gudasheva   +2 more
openaire   +2 more sources

[Behavior of mice from different strains: modifications produced by noopept].

Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova, 2008
Genotype-dependent behavioral effects were demonstrated in BALB/c, C57BL/6J [Russian character: see text] DBA/2J mice after injections of nootropic drug Noopept. In an elevated plus maze, drug administration induced an increase in the number of enterings into bright arms in BALB/c mice, whereas the opposite effect was observed in C57BL/6J.
A P, Bel'nik, R U, Ostrovskaia, I I, Poletaeva   +2 more
openaire   +1 more source

[Noopept in the treatment of mild cognitive impairment in patients with stroke].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2012
Noopept is a neuroprotector and nootropics. Literature data revealed the treatment effect of noopept on mild cognitive impairment in patients with discirculatory encephalopathy. The present open prospective study included 60 patients with stroke treated with noopept during 12 months.
A V, Amelin, A Iu, Iliukhina, A A, Shmonin   +2 more
openaire   +1 more source

Correction of alcohol-induced disorders of working memory with noopept

Molekulyarnaya Meditsina (Molecular medicine), 2022
Larisa Gennadievna Kolik, Vasiliy Grigorievich Konkov, Alexandra Valrr’yanovna Sorokina, Irina Alexsandrovna Miroshkina, Kirill Alekseevich Kasabov, Vladimir Sergeevich Kudrin, Andrey Dmitrievich Durnev   +6 more
openaire   +1 more source

[Prevention of neuro- and cardiotoxic side effects of tuberculosis chemotherapy with noopept].

Klinicheskaia meditsina, 2009
The study evaluated clinical efficiency of noopept used to prevent adverse side effects of antituberculous agents. It included 60 patients with newly diagnosed respiratory tuberculosis. Those in group 1 (n = 30) received 10 mg of noopept twice daily during the first month. The treatment promoted functional normalization of vegetative nervous system and
A V, Mordyk, A V, Lysov, A V, Kondria, M A, Gol'dzon, N V, Khlebova   +4 more
openaire   +1 more source

Bioaccessibility of the new dipeptide nootropic drug noopept

Pharmaceutical Chemistry Journal, 2004
S. S. Boiko, V. P. Zherdev, T. A. Gudasheva, R. U. Ostrovskaya, S. A. Korotkov, O. Yu. Kravtsova   +5 more
openaire   +1 more source

P.5.039 Experimental and clinicalpharmacokinetics of noopept

European Neuropsychopharmacology, 2005
openaire   +1 more source

P.5.037 Clinical pharmaco-EEG characteristic ofthe novel nootropic drug noopept

European Neuropsychopharmacology, 2005
I.A. Davidova, V.K. Bochkarev, G.G. Neznarnov   +2 more
openaire   +1 more source

[Efficacy of noopept in discirculatory encephalopathy].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010
E R, Barantsevich, O V, Posokhina, Iu V, Sturova   +2 more
openaire   +1 more source

P.5.038 Clinical pharmacological study of thenovel peptide nootropic drug noopept

European Neuropsychopharmacology, 2005
E.S. Teleshova, I.A. Davydova
openaire   +1 more source